Craft

Eckert & Ziegler

Stock Price

€41.8

2024-10-29

Market Capitalization

€972 M

2023-05-03

Revenue

€246.1 M

FY, 2023

Eckert & Ziegler Summary

Company Summary

Overview
Eckert & Ziegler provides isotope technology components for medical, scientific, and industrial use worldwide. It develops, manufactures, markets, and sells radioactive products for cancer therapy. The Company also operates in the field of molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. Besides, it offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers.
Type
Public
Status
Active
Founded
1997
HQ
Berlin, DE | view all locations
Website
https://www.ezag.com/home/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Dirk W. Becker, Managing Director

    LocationsView all

    19 locations detected

    • Berlin, Berlin HQ

      Germany

      Robert-Rössle-Straße 10

    • Atlanta, GA

      United States

      1380 Seaboard Industrial Blvd NW

    • Santa Clarita, CA

      United States

      24937 Ave Tibbitts

    • Wilmington, MA

      United States

      25 Upton Dr

    • Buenos Aires, Cdad. Autónoma de Buenos Aires

      Argentina

      Arias 4149

    • São Paulo, SP

      Brazil

      Rua Miguel Nelson Bechara, 480 Limão

    and 13 others

    Eckert & Ziegler Financials

    Summary Financials

    Revenue (Q3, 2024)
    €70.1M
    Gross profit (Q3, 2024)
    €37.8M
    Net income (Q3, 2024)
    €9.4M
    Cash (Q3, 2024)
    €97.6M
    EBIT (Q3, 2024)
    €16.0M
    Enterprise value
    $926.2M

    Footer menu